A detailed history of Northstar Group, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Northstar Group, Inc. holds 3,000 shares of NVO stock, worth $262,110. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,000
Previous 3,336 10.07%
Holding current value
$262,110
Previous $476,000 25.0%
% of portfolio
0.06%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$119.07 - $145.42 $40,007 - $48,861
-336 Reduced 10.07%
3,000 $357,000
Q2 2024

Jul 17, 2024

SELL
$122.71 - $146.91 $39,758 - $47,598
-324 Reduced 8.85%
3,336 $476,000
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $373,722 - $497,467
3,660 New
3,660 $469,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northstar Group, Inc. Portfolio

Follow Northstar Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.